Vascular Cartographic Scanning Nanodevice (VCSN)
Frank Boehm’s book Nanomedical Device and Systems Design, Challenges, Possibilities, Visions endeavors to explore and present concepts for advanced nanomedical components, devices, and systems that may emerge over the next ~10-30 years. One of these nanodevices is called the Vascular Cartographic Scanning Nanodevice (VCSN) (Figure 1), which would be manifest as an autonomous, ~1 micron in diameter nanomedical device.
Figure 1: Artistic representation of conceptual Vascular Cartographic Scanning Nanodevice (VCSN)
Up to perhaps many thousands, or tens of thousands of VCSN nanodevices might be introduced into the patient intravenously, via ingestion as a pill, through inhalation, transdermally using a patch, or migrate in vivo utilizing a topical gel. Once within the patient their purpose would be to rapidly scan the entire human vasculature down to the smallest capillary lumen (~3 microns in diameter) in ultrahigh-resolution (sub-micron) three-dimensional (3D) digitized format. At all times they would be under the complete control of the surgeon or physician via “outbody” computer commands. Some of the capabilities of the VCSN are listed below:
- Capable of generating a very high-resolution (under 1 micron) 3D rendering of the complete human vasculature down to the smallest capillaries. It may also be applied to the imaging of the lymphatic system, and in a simplified form, the gastrointestinal tract, using a Gastrointestinal Micro Scanning Device (GMSD), (see description below).
- Ability to distinguish vascular and neurological plaque deposits and lesions with high accuracy.
- Capacity to determine vascular wall thicknesses, along with the identification and highlighting of any “hot spot” sites within the vasculature, such as imminent blockages or aneurysms that are at risk of rupturing.
- Surgeon and physicians would be able to “fly-through” all scanned areas via a joystick and computer display for the highly detailed inspection of any desired site within the system. The acquired spatial data from the VCSN may also enable holographic rendering and virtual travel through all imaged systems.
- Ability to facilitate the targeting of tumors by revealing sites of angiogenesis in close proximity to tumor growth sites.
A number of advantages of the VCSN include:
- High compactness and portability as its operation will require a relatively small footprint. This would enable a simple and quick setup and power-up procedures, which will be a boon for applications in developing countries and remote terrestrial environments.In aerospace, it might be utilized as an element of an on board medical diagnostics suite on military and medical aircraft.
- For space travel, it may be reconfigured for integration into spacesuits and spacecraft, and provide a compact yet very powerful medical imaging capability for future Moon and Mars habitats.
- Frugal energy consumption.
- Inexpensive administration and operation
- Rapid scanning time (~5 minutes).
- Ultrahigh resolution digital imagery and inherent flexibility for display across several formats and ease of file transmission to medical personnel globally via secure telecommunications connectivity
- Potential for enabling the significant reduction or elimination of long waiting queues for critical imaging technologies.
Gastrointestinal Micro Scanning Device (GMSD)
The Gastrointestinal Micro Scanning Device (GMSD) (Figure 2) will serve as far less complex precursor to the VCSN as it will not have the capacity for propulsion or navigation. It might, however, employ nascent forms of quantum computing, nanoelectronics, spatial data acquisition, and Pixel Matrix (see below) technologies that are envisaged for the VCSN. Hence, in addition to serving as formative in vivo spatial data acquisition device, the GMSD may also have utility as a test bed of sorts that is employed to identify and resolve technical, integrative, and functional issues toward the development of the VCSN.
Figure 2: Artistic representation of conceptual Gastrointestinal Micro Scanning Device (GMSD)
The GMSD system will consist of three distinct components that work in unison to generate very high-resolution 3D topography of the entire internal surface of the GIT. The GMSD would accomplish this task by utilizing:
- Bright Ball (BB) scanning device, which would have a smooth spherical morphology of ~3 mm in diameter
- Pulse Generator/Data Transfer (PGDT) unit would trigger the activity of the internalized BB device via a specifically encrypted signal. The BB would be activated to scan subsequently to receiving this specific signal only. Once activated, the BB would commence to transmit a constant spatial data stream to the PGDT, which would serve as a data transfer device when linked to a computer and the Pixel Matrix (see below) software. The PGDT would be securely affixed to the patient’s abdominal surface and would stay in place for the duration of the scan.
- The Pixel Matrix display would process the PGDT supplied spatial data toward the reconstruction a high resolution “pixel per hit” 3D rendering of the total scanned area of the GIT that has been traversed by the BB. This software would enable “fly-through” and cross-sectional capabilities, allowing medical personnel to traverse the entire GIT (using a joystick, computer mouse, or touch screen display) to investigate any potential problem areas in great detail. The spatial data might also be converted to holographic and virtual reality formats. Using this procedure, the physician and/or surgeon would thus recognize any anomalous topography that is associated with tumor growth, lesions, and other abnormal features that may exist within the GIT.
The operational procedure for the GMSD would be relatively simple to implement, as the BB would be introduced orally to the patient in the same manner as a pill. Subsequently, an adhesive waterproof thin film PGDT patch would be affixed to the skin of patient’s abdomen. At this juncture, a system calibration would be performed to ensure that the communication link between the BB and the PGDT is functioning properly. An initial test scan would also be conducted in order to configure the image resolution. The PGDT would emit a unique pulsed signal (e.g., ultrasonic, near-infrared), which when received by sensors embedded within the surface of the BB would trigger all of the embedded emitters/receivers to fire and emit their scanning beams simultaneously in every direction. Once these procedures are completed the patient would be allowed to leave the physician’s office, clinic, or hospital to go about his/her normal routine. The internalized BB would now move along with the natural peristaltic rhythms of the GIT and be naturally eliminated at the conclusion of the transit duration. The patient would then return to the facility in two or three days (contingent on the assessed GIT transit time) to have the PGDT patch removed.
During the designated scanning period, the PGDT will have been continuously uploading spatial data provided by the BB, which would then be interfaced with a computer via a USB port to stream all of this data to the PM software housed within the computer. The data would now be translated to high-resolution 3D imagery on a display. The PM software would calculate BB orientation and would correlate the interrogating hits obtained within predetermined parameters to construct a cross section of the GIT to depict its internal topography. These digitized fragments would then be sequentially pieced together to form a seamless spatially accurate rendering of the system.
LAS CRUCES, N.M. — Members of an independent NASA safety panel said they were worried that the Oct. 11 Soyuz launch failure could make safety concerns with the agency's commercial crew program even worse. [...]
Canadian astronaut Col. Chris Hadfield (Ret.) on Friday said that human travel to space will happen sooner than we think, adding that the first destination will likely be a return trip to the moon. [...]
Antibody-based imaging of a particularly aggressive form of breast cancer is undergoing clinical trials worldwide, but the path from trial to application is being hampered by a major obstacle: safety. Concerns stem from inefficient [...]
Following the discovery of graphene in 2003, there has been considerable interest in other types of 2D materials. However, splitting a bulk crystal material into 2D flakes for use in electronics has proven hard [...]
The digital economy is set to unlock tremendous economic value for countries over time. But a common setback for the use of various new technologies is their vulnerability to hackers. That's because companies and [...]
Nanomedical Device and Systems Design: Challenges, Possibilities, Visions now available to rent on Kindle
To accommodate students who wish to read the book at an affordable cost, Nanomedical Device and Systems Design: Challenges, Possibilities, Visions by Frank Boehm (CEO NanoApps Medical Inc.) is available to rent on Kindle. This book benefits [...]
The last five years has seen a surge of attacks on the healthcare industry, with the largest breaches impacting as many as 80 million people. In July this year, it was revealed that 150,000 [...]
The Nanoaugmented Materials Industry Summit (NAUM) 2018 in Shanghai on October 31 will gather the world’s leading companies who use and apply graphene nanotubes to share exciting results. This year the event is opening [...]
Any truck operator knows that hydraulics do the heavy lifting. Water does the work because it's nearly incompressible at normal scales. But things behave strangely in nanotechnology, the control of materials at the scale [...]
Myeloperoxidase - an enzyme naturally found in our lungs - can biodegrade pristine graphene, according to the latest discovery of Graphene Flagship partners in CNRS, University of Strasbourg (France), Karolinska Institute (Sweden) and University [...]
In today’s hospitals and healthcare clinics, a new doctor’s new assistant is now often on the job — in the form of artificial intelligence. Whether it’s analyzing medical images or guiding robots that assist [...]
Healthcare cybersecurity will be one of the top 10 challenges, issues, and/or opportunities facing healthcare executives next year, according to a new poll by the Healthcare Executive Group (HCEG). Healthcare cybersecurity covers such issues [...]
A research team has developed a nano-platform technology that works in combination with existing chemotherapeutic drugs that may reverse drug-resistance in renal cell carcinoma. Drug resistance to chemotherapy is a significant clinical and financial [...]
After six years of design and construction, MIT.nano will celebrate the completion of the facility at a Grand Opening Event on Oct. 4. Please join us for a day of activities including a symposium [...]
If nanotechnology has one clear image in the collective pop-culture consciousness, it is that of nanorobots, nanoscale machines capable of performing mechanical functions. When considering the potential of such a technology, the more astute may [...]
Artificial intelligence (AI) is clearly a growing force in the technology industry. Chatbots and virtual assistants are becoming a key part of new products, and robots are taking center stage at conferences and showing [...]
In what seems like the blink of an eye, mentions of artificial intelligence have become ubiquitous in the healthcare industry. From deep learning algorithms that can read CT scans faster than humans to natural [...]
The International Conference On Nanomedicine And Nanobiotechnology is an annual event. It hosts high-profile plenary speakers, world-class researchers, oral and poster presentations, workshops, sponsor exhibits and afterworks. It is a great opportunity to share [...]
SYDNEY, (UrduPoint / Pakistan Point News, app - 14th Sep, 2018 ) :Scientists in Australia have developed a ground-breaking new way to strip impurities from waste water, with the research set to have massive [...]
Two teams of scientists from the Technion-Israel Institute of Technology have collaborated to conduct groundbreaking research leading to the development of a new and innovative scientific field: Quantum Metamaterials. The findings are presented [...]
A team of eight EPFL students has come up with a portable biosensor that can measure the amount of vancomycin in a patient's blood stream, enabling doctors to better control the dosage and reduce [...]
Researchers have developed a see-through, dual-layered, mesh EEG device which is capable of measuring the electrical activity of individual neurons… Researchers from Boston Children’s Hospital and Northeastern University developed a ‘see-through’ EEG device to [...]
VILLEJUIF, France--(BUSINESS WIRE)--A study published in The Lancet Oncology establishes for the first time that artificial intelligence can process medical images to extract biological and clinical information. By designing an algorithm and developing it [...]
From #AskTheCEO on YouTube: Dr. Johannes Drooghaag is the CEO of Spearhead Management, in Germany. He is an accomplished speaker in the areas of Executive Leadership, Blockchain, Artificial Intelligence, Agile Business Management. He [...]
Scientists have used artificial intelligence to predict how cancers will progress and evolve. This could help doctors design the most effective treatment for each patient. A team led by the Institute of Cancer Research [...]
From #AskTheCEO on YouTube: David Houlding is the Worldwide Healthcare Industry Leader on the Microsoft Azure Industry Experiences Team led by Paul Maher. David has more than 24 years of experience in healthcare [...]